We are live on ! Find out more
Boston Partners

Boston Partners Portfolio holdings

AUM $95.5B
1-Year Est. Return 28.4%
This Fund
S&P 500
This Quarter Est. Return
+8.8%
1 Year Est. Return
+28.4%
3 Year Est. Return
+84.58%
5 Year Est. Return
+116.72%
10 Year Est. Return
+426.49%
AUM
$83B
AUM Growth
+$4.08B
Cap. Flow
-$2.07B
Cap. Flow %
-2.5%
Top 10 Hldgs %
13.18%
Holding
730
New
59
Increased
161
Reduced
398
Closed
45

Top Sells

Rank Stock Value
1
PFE icon
Pfizer
PFE
+$433M
2
LOW icon
Lowe's Companies
LOW
+$277M
3
ORCL icon
Oracle
ORCL
+$226M
4
PGR icon
Progressive
PGR
+$220M
5
LVS icon
Las Vegas Sands
LVS
+$167M

Sector Composition

Rank Sector Weight
1 Financials 19.96%
2 Healthcare 15.3%
3 Industrials 15.12%
4 Technology 14.91%
5 Consumer Discretionary 11.12%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
RCL icon
276
Royal Caribbean
RCL
$81.8B
$35.1M 0.04%
456,356
-3,253
-0.7% -$264K
PETQ
277
DELISTED
PetIQ, Inc. Class A Common Stock
PETQ
$34.8M 0.04%
1,541,272
+327,174
+27% +$7.65M
SBH icon
278
Sally Beauty Holdings
SBH
$1.43B
$34.8M 0.04%
1,882,611
-21,643
-1% -$394K
PM icon
279
Philip Morris
PM
$305B
$34.5M 0.04%
363,072
-29,482
-8% -$2.76M
PRA
280
DELISTED
ProAssurance
PRA
$34.3M 0.04%
1,356,452
-9,298
-0.7% -$222K
KGC icon
281
Kinross Gold
KGC
$28.6B
$33.9M 0.04%
4,622,466
+1,700,591
+58% +$10.2M
MATV icon
282
Mativ Holdings
MATV
$455M
$33.9M 0.04%
1,126,321
-10,108
-0.9% -$333K
CX icon
283
Cemex
CX
$17.6B
$32.9M 0.04%
4,860,233
-287,788
-6% -$1.87M
PRAA icon
284
PRA Group
PRAA
$683M
$32.7M 0.04%
652,201
-4,630
-0.7% -$206K
UMPQ
285
DELISTED
Umpqua Holdings Corp
UMPQ
$32.4M 0.04%
1,669,992
-10,240
-0.6% -$207K
MTH icon
286
Meritage Homes
MTH
$4.89B
$32.3M 0.04%
535,250
-3,174
-0.6% -$177K
FTDR icon
287
Frontdoor
FTDR
$5.1B
$32.2M 0.04%
874,349
-70,975
-8% -$2.69M
ISBC
288
DELISTED
Investors Bancorp, Inc.
ISBC
$31.4M 0.04%
2,044,904
-14,013
-0.7% -$216K
UVV icon
289
Universal Corp
UVV
$1.34B
$31.3M 0.04%
567,600
-4,177
-0.7% -$208K
UIS icon
290
Unisys
UIS
$245M
$31.3M 0.04%
1,519,300
-8,306
-0.5% -$183K
HOUS
291
DELISTED
Anywhere Real Estate
HOUS
$31.2M 0.04%
1,865,605
+98,279
+6% +$1.71M
CCL icon
292
Carnival Corporation Ltd
CCL
$37.1B
$31.1M 0.04%
1,547,659
-6,948
-0.4% -$149K
MAN icon
293
ManpowerGroup
MAN
$2.5B
$30.9M 0.04%
317,835
-18,861
-6% -$1.89M
HBI
294
DELISTED
Hanesbrands
HBI
$30.1M 0.04%
1,792,942
-1,963
-0.1% -$33.4K
SKX
295
DELISTED
Skechers
SKX
$30M 0.04%
684,616
-5,167
-0.7% -$232K
AVT icon
296
Avnet
AVT
$7.25B
$29.5M 0.04%
714,206
+98,238
+16% +$3.79M
NCLH icon
297
Norwegian Cruise Line
NCLH
$9.2B
$29.1M 0.04%
1,401,178
-10,303
-0.7% -$246K
HP icon
298
Helmerich & Payne
HP
$3.36B
$29M 0.03%
1,200,908
-5,653,963
-82% -$161M
HI
299
DELISTED
Hillenbrand
HI
$27.5M 0.03%
527,980
-4,181
-0.8% -$200K
NMIH icon
300
NMI Holdings
NMIH
$3.27B
$27.3M 0.03%
1,238,618
-9,935
-0.8% -$221K

Similar funds

Boston Partners's Q4 2021 Portfolio in Review

As of Q4 2021, Boston Partners held 730 positions worth $83B, up 5.2% from $78.9B the previous quarter. Its ten largest holdings account for 13% of the portfolio.

Boston Partners's Q4 2021 filing shows 59 new, 161 increased, 398 reduced and 45 closed positions. Its largest new stake was Keurig Dr Pepper: 15,605,496 shares worth $575M. The largest sale was Pfizer, an estimated $433M.

By sector, the portfolio is most concentrated in Financials at 20% of assets, down from 22% a quarter earlier, followed by Healthcare and Industrials.

  • Boston Partners's largest Q4 2021 buy was Keurig Dr Pepper: 15,605,496 shares worth $575M.
  • Boston Partners added most to Fidelity National Information Services in Q4 2021, an estimated $353M increase.
  • Boston Partners's biggest Q4 2021 reduction was Pfizer, cutting an estimated $433M.
  • Boston Partners fully exited CyrusOne Inc Common Stock in Q4 2021, selling an estimated $137M.
  • Boston Partners's ten largest holdings make up 13% of its $83B portfolio in Q4 2021.
  • Boston Partners opened 59 new positions and closed 45 in Q4 2021.
  • Boston Partners's portfolio value rose 5.2% quarter-over-quarter to $83B.

Based on Boston Partners's 13F filing for Q4 2021, filed 4 Feb 2022.